Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …

Background & Aims The presence of portal vein tumor thrombosis (PVTT) in patients with
hepatocellular carcinoma (HCC) is regarded as indicating an advanced stage, and liver …

Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis
and clinical staging of hepatocellular carcinoma (HCC). We have published the first version …

Because of the rarity of hepatic vein tumor thrombus (HVTT) compared with portal vein tumor
thrombus (PVTT) in patients with hepatocellular carcinoma, little is known about this disease …

Portal vein tumor thrombus (PVTT) is very common, and it plays a major role in the
prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the …

Objectives To evaluate the feasibility and efficacy of stereotactic body radiation therapy
(SBRT) in the treatment of hepatocellular carcinoma (HCC) unsuitable for standard loco …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

MR guided radiotherapy represents one of the most promising recent technological
innovations in the field. The possibility to better visualize therapy volumes, coupled with the …

Many patients with hepatocellular carcinoma (HCC) present with advanced disease, not
amenable to curative therapies such as surgery, transplantation or radiofrequency ablation …